Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
By Dilip Cherian The death of Rakesh Mehta, former Chief Secretary of Delhi, is deeply saddening. But beyond the shock...
Read moreDetailsIt is surprising that the administration in Paris, France, in charge of managing institutions like the Eiffel Tower bent over...
Read moreDetailsThe judiciary is one of the three pillars of Indian democracy that the people traditionally trust, most for the redress...
Read moreDetailsResearch and Development (R&D) is always considered the most expensive or cost intensive part of any new product. Deep pockets...
Read moreDetails

